Immunogenicity of infectious pathogens and vaccine antigens

47Citations
Citations of this article
144Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The concept of the immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. However, the theoretical notion of immunogenicity as discussed in older textbooks of immunology needs reconsideration due to advances in our understanding of immunologic responses. Immunogenicity is a property that can either be a desirable attribute, for example in the generation of an effective protective immunity against infectious pathogens or an undesirable trait, for example when it relates to novel therapeutic compounds and drugs, where an immune response needs to be prevented or inhibited. In this Forum Article, we aimed to revisit the issue of immunogenicity to discuss a series of simple questions relevant to the concept that are frequently rephrased but incompletely resolved in the immunologic literature.

Cite

CITATION STYLE

APA

Mahanty, S., Prigent, A., & Garraud, O. (2015). Immunogenicity of infectious pathogens and vaccine antigens. BMC Immunology, 16(1). https://doi.org/10.1186/s12865-015-0095-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free